# TCR2 THERAPEUTICS INC.

TCR2 THERAPEUTICS INC. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** TCR2 THERAPEUTICS INC.
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001750019

## About

TCR2 THERAPEUTICS INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001750019, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2023-03-23, it reported net income of USD -151,822,000; total assets of USD 208,236,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$151.8M (USD -151,822,000)
- **Total assets:** $208.2M (USD 208,236,000)
- **Cash and equivalents:** $32.7M (USD 32,746,000)
- **Operating cash flow:** -$101.5M (USD -101,461,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$99.8M (USD -99,807,000)
- **Total assets:** $323.4M (USD 323,371,000)
- **Cash and equivalents:** $222.6M (USD 222,564,000)
- **Operating cash flow:** -$81.6M (USD -81,603,000)

### FY2020 (period ended 2020-12-31)

- **Net income:** -$67.1M (USD -67,124,000)
- **Total assets:** $246.2M (USD 246,195,000)
- **Cash and equivalents:** $94.2M (USD 94,155,000)
- **Operating cash flow:** -$56.7M (USD -56,739,000)

### FY2019 (period ended 2019-12-31)

- **Net income:** -$47.6M (USD -47,599,000)
- **Total assets:** $168.5M (USD 168,528,000)
- **Cash and equivalents:** $65.3M (USD 65,296,000)
- **Operating cash flow:** -$41.4M (USD -41,359,000)

## Recent SEC filings

- Form 8-K — filed 2023-06-01 — period 2023-06-01 — FORM 8-K
- Form 8-K — filed 2023-05-30 — period 2023-05-30 — FORM 8-K
- Form 8-K — filed 2023-05-24 — period 2023-05-23 — 8-K
- Form 8-K — filed 2023-05-22 — period 2023-05-22 — FORM 8-K
- Form 10-Q — filed 2023-05-11 — period 2023-03-31 — 10-Q
- Form 8-K — filed 2023-05-11 — period 2023-05-11 — 8-K
- Form 10-K — filed 2023-03-23 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-03-23 — period 2023-03-23 — 8-K
- Form 8-K — filed 2023-03-10 — period 2023-03-10 — 8-K
- Form 8-K — filed 2023-03-06 — period 2023-03-05 — FORM 8-K
- Form 8-K — filed 2023-01-05 — period 2023-01-05 — 8-K
- Form 8-K — filed 2023-01-03 — period 2023-01-01 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/tcr2-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology